Browsing: News

News
0 Lean year ahead for IPOs but 2019 looks brighter – Chapman Tripp

Competition for assets from private equity firms made 2017 a very quiet year for initial public offers, despite the sharemarket rallying by more than 20 per cent, says Chapman Tripp.

The law firm, in a report on New Zealand’s equity capital markets, said last year was the worst for initial public offerings since 2013. The current year is expected to be similarly quiet before IPO activity picks up again in 2019, it said.

“I think that strong competition – still – for quality assets is the issue,” said Chapman Tripp partner Rachel Dunne.

Read more

News
0 Postr Announces $2.5 Million Funding with Key New Hires

Ad tech company Postr has today announced it has closed a $2.5 million funding round led by an investment group of Koh Boon Hwee. MDI Ventures, the corporate VC of SEA giant Telkom Indonesia, participated as well as existing investors, NZVIF (The New Zealand Venture Investment Fund) and Sir Stephen Tindall’s K1W1. This latest round brings the total raised since the company’s launch in 2014 to $5.5 million.

Postr enables carriers to integrate lock screen advertising and sponsored data capabilities into their apps, generating new mobile ad revenues and offering rewards such as free data and minutes to subscribers. Advertisers gain high quality inventory and guaranteed viewability with users unlocking their phones up to 80 times a day.

Read more

News
0 Turn Your Innovative Ideas into Gold through Investment

All businesses need capital to grow. To scale up and make it on the world stage you need investment. There are plenty of different funding options available ranging from bank loans to online investment, venture capital and private equity. What are the advantages of each, and what do investors look for in a potential investment?

To learn the answers to these questions, join national intellectual property specialists James & Wells at Turning Innovation into Gold: Attracting Investment, a nationwide seminar series. The series will see James & Wells team up with successful entrepreneurs and investment providers to answer funding questions and provide practical advice on how to get investment ready.

Read more

News
0 Kiwi company receives over US$8.5 million in financing round

Exascale computing company, Nyriad, announced that it has completed its Series A investment round, bringing it to a total of over US$11 million raised to date.

The funds will be used to support the continuing expansion of the business in Cambridge, New Zealand, including further investment in expanding its engineering resources and release of its first product to market in Q1’18.

Read more

News
0 Sydney biotech Elastagen has just been bought for $120 million by the maker of Botox

University of Sydney spin-off Elastagen, which has a product to fix stretch marks and acne scars, has been bought by multi billion dollar global biopharmaceutical Allergan, the manufacturer of Botox, for $US95 million ($A120 million).

Elastagen’s technology is based on human tropoelastin, the precursor of elastin which is a key component of youthful skin.

The startup is part of the Medical Research Commercialisation Fund portfolio, managed by Brandon Capital Partners.

Read more

1 2 3 75